Equity Analysis

Quarterly Results

    Caplin Point Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524742
    INE475E01026
    182.8879518
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    CAPLIPOINT
    54.94
    15381.35
    EPS(TTM)
    Face Value()
    Div & Yield %:
    36.83
    2
    0.25
     
Quarters
(RupeeIcon Cr)
ParticularsJun 2024Mar 2024Dec 2023
Gross Sales185.64139.38132.83
Other Operating Income0.000.000.00
Other Income 21.5036.1817.90
Total Income207.14175.56150.73
Total Expenditure 104.2681.7069.51
PBIDT102.8893.8681.22
Interest 0.020.020.03
PBDT102.8693.8481.19
Depreciation6.186.936.76
Tax24.5717.2219.91
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.43-0.19-0.93
Reported Profit After Tax72.5469.8855.45
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item72.5469.8855.45
EPS (Unit Curr.)9.559.207.30
EPS (Adj) (Unit Curr.)9.559.207.30
Calculated EPS (Unit Curr.)9.549.207.30
Calculated EPS (Adj) (Unit Curr.)9.549.207.30
Calculated EPS (Ann.) (Unit Curr.)38.1836.8029.20
Calculated EPS (Adj) (Ann.) (Unit Curr.)38.1836.8029.20
Book Value (Unit Curr.)0.000.000.00
Dividend (%)125.000.000.00
Equity15.2015.1915.19
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)55.4267.3461.15
PBDTM(%)55.4167.3361.12
PATM(%)39.0850.1441.75
Dividend Per Share(Rs)2.500.000.00
Diluted EPS9.509.147.29